Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 6/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | ECE1 | P42892 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25140517 | 0.80 | — | — | |
| SCHEMBL19070090 | 0.75 | — | — | |
| SCHEMBL24359598 | 0.71 | GAA (0.52) | ALDH1A1GAAKDM4ERECQLPOLB | |
| SCHEMBL22692440 | 0.71 | MAPT (0.59) | ALDH1A1GAAKDM4ERECQLPOLB | |
| SCHEMBL25140637 | 0.69 | RAB9A (0.35) | ALDH1A1GAAKDM4EPOLBMAPT | |
| SCHEMBL19447578 | 0.68 | CCR1 (0.52) | RECQL | |
| SCHEMBL8472582 | 0.68 | ALDH1A1 (0.37) | ALDH1A1HPGD | |
| SCHEMBL23714944 | 0.67 | GAA (0.42) | ALDH1A1GAAKDM4ERECQLPOLB | |
| SCHEMBL13270383 | 0.66 | NPC1 (0.36) | GAAKDM4EPOLBHPGDMAPT | |
| SCHEMBL22692417 | 0.63 | RECQL (0.38) | ALDH1A1GAAKDM4ERECQLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3799871-B1 | PYRAZOL-3-ONES THAT ACTIVATE PRO-APOTOTIC BAX | DANA FARBER CANCER INST INC (US) | 2024-02-28 | — | — | EP | disclosed |
| US-10844053-B2 | Pyrazol-3-ones that activate pro-apoptotic BAX | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844053-B2 | Pyrazol-3-ones that activate pro-apoptotic BAX | BAX, BAD, CASP3 | ALDH1A1 3612/4885GAA 1708/4885KDM4E 4573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.